QA: Viracta Therapeutics Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001061027_2020_Viracta_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001061027, Viracta Therapeutics Inc

  xvar xval
0 AssetsCurrent 36,322,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,000
3 remainder_Assets 915,000
4 LiabilitiesCurrent 9,416,000
5 LiabilitiesNoncurrent 281,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,943,090
9 ResearchAndDevelopmentExpense 15,690,371
10 remainder_Expenses 413,634
11 remainder_Revenues 1,758,084
12 remainder_NetIncome 393,694
13 remainder_ComprehensiveNetIncome 2,403
  yvar yval
0 Assets 37,240,000
1 Liabilities 9,697,000
2 Expenses 26,047,095
3 Revenues 1,758,084
4 StockholdersEquity 27,543,000
5 NetIncome -23,895,317
6 ComprehensiveNetIncome -23,894,116
7 BaseVar 37,569,138
8 EconomicCapitalRatiobeforeLimitedLiability 1.54
9 EconomicCapitalRatio 2.71

Edgar->Model Mapping

Feature Distribution

Change over Time